ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong · Delayed Price · Currency is HKD 3.150
-0.050 (-1.56%)
Sep 18, 2026, 4:08 PM HKT
ImmuneOnco Biopharmaceuticals (Shanghai) Employees
ImmuneOnco Biopharmaceuticals (Shanghai) had 197 employees as of June 30, 2026. The number of employees decreased by 5 or -2.48% since the number was reported on December 31, 2025.
Employees
197
Change
-5
Growth
-2.48%
Revenue / Employee
864.55K HKD
Profits / Employee
-1.35M HKD
Market Cap
1.35B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 197 | -5 | -2.48% | 197 | 0 |
| Dec 31, 2025 | 202 | 46 | 29.49% | 201 | 1 |
| Dec 31, 2024 | 156 | 11 | 7.59% | 156 | 0 |
| Dec 31, 2023 | 145 | - | - | 145 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1,787 |
| Shandong Boan Biotechnology | 690 |
| Mabpharm | 394 |
| Zhaoke Ophthalmology | 285 |
| TYK Medicines | 184 |
| Beijing Biostar Pharmaceuticals | 127 |
| SinoMab BioScience | 95 |
| Cloudbreak Pharma | 61 |